Mega Genomics
Haidian
About Mega Genomics
Mega Genomics provides platforms for genetic testing, including cancer screening and consumer-grade genetic testing. In terms of the total number of tests run, it is a consumer-grade genetic testing platform. In terms of the total number of tests it performs, it is also a genetic testing platform for cancer screening. In order to address the rising demand from patients for preventative medical care, they introduce hundreds of testing services that cover an array of topics like nutrition and metabolism, cancer risk assessment, susceptibility to chronic diseases, cancer screening, and infectious illness detection. With the help of inclusive genetic testing services and genetic testing technologies, they are unraveling the secrets of DNA and promoting human health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $63.2M
- Funding stage: IPO
- Last round: Series Unknown (Jan 2020)
- Ticker: hkg:6667
- Website: megagenomics.cn
- Phone: +86 400-008-0280
Industries & Categories
Health Care, Medical, Personal Health
Social Profiles
Canonical: https://fsome.com/organization/mega-genomics-24377 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.